Using clinical and expression data from TCGA database and our own center, we found that LINC00261 was significantly downregulated in pancreatic cancer tissues, correlated with advanced pathological stage, and had the potential to be a prognostic marker, which suggested that LINC00261 might be involved in the progression of pancreatic cancer. Here, LINC00261 is linked to familial pancreatic carcinoma.